In this assay, SNs showed reparative abilities, and inhibiting the EGFR signaling pathway by Cetuximab abrogated these reparative abilities (Fig. 4 A and Fig. S3 A), as observed previously with influenza-specific CD8 T cells (Fig. 1). The gene discussed is CD8A; the disease is influenza.